We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
We would like your views on a review of temporary provisions in the Human Medicines Regulations to support influenza and COVID-19 vaccination campaigns.
First published during the 2019 to 2022 Johnson Conservative government
An agreement between DHSC and the ABPI on getting the best value and most effective medicines into use more quickly.
First published during the 2016 to 2019 May Conservative government
The medicines regulators from Australia, Canada, Singapore, Switzerland and the United Kingdom (Access Consortium) have discussed the continued need for COVID-19 medicines that are safe, effective and of high quality
We want your views on proposals for changing how community pharmacy contractors in England are paid for the drugs they dispense against NHS prescriptions.
Details the government's response to the IMMDS Review report. Sets out action the government will take to implement the recommendations accepted and improve patient safety.
A 3-week public consultation on a proposal to make Hana 75 microgram film-coated tablets (Desogestrel) available from pharmacies.
A 3-week consultation on a proposal to make Lovima 75 microgram film-coated tablets (Desogestrel) available from pharmacies.
Review of the first 12 months of the serious shortage protocols (SSPs) policy for managing and mitigating medicines shortages.
We’re looking for views from patients and the public on how we engage with them.
The MHRA is asking for views on a proposal to make Nuromol Dual Action Pain Relief 200mg/500mg tablets (ibuprofen/paracetamol) available without prescription in general sales outlets, such a supermarkets.
We want your comments on the clarity and wording of our new guidance
The medicine regulators from Australia, Canada, Singapore, Switzerland and the United Kingdom (Access Consortium) have discussed the regulatory evidence requirements for COVID-19 vaccine approvals and considerations for post…
This consultation asks for views on the application of AQbD principles to pharmacopoeial standards for medicinal products.
Work is ongoing to address the comments and feedback from respondents to the consultation. Publication of our report on the consultation has been delayed in light of the Agency’s response during the ongoing coronavirus situa…
Proposed changes to the statutory scheme to control the costs of branded health service medicines.
Impact assessment evaluating the measures in the Medicines and Medical Devices Bill, and illustrative statutory instruments showing how powers in the bill may be used.
We are seeking views on a proposal to make Acnecide Face 5% w/w Gel and Acnecide Face Wash 5% w/w Gel available from general sales outlets.
The government's response to the Health and Social Care Committee's report.
We are asking for views on a new draft version on our guidance for users, carers and staff on the safe use of bed rails.
The Home Secretary has formally commissioned the Advisory Council on the Misuse of Drugs (ACMD) to conduct a longer-term review of cannabis-based products for medicinal use.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).